Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

High Mobility Group Box Protein 1 (HMGB1): The Prototypical Endogenous Danger Molecule
Huan Yang, Haichao Wang, Sangeeta S. Chavan, et al.
Molecular Medicine (2015) Vol. 21, Iss. S1, pp. S6-S12
Open Access | Times Cited: 317

Showing 1-25 of 317 citing articles:

Detection of immunogenic cell death and its relevance for cancer therapy
Jitka Fučíková, Oliver Kepp, Lenka Kašíková, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 11
Open Access | Times Cited: 758
Mechanisms and treatment of organ failure in sepsis
Christophe Lelubre, Jean‐Louis Vincent
Nature Reviews Nephrology (2018) Vol. 14, Iss. 7, pp. 417-427
Closed Access | Times Cited: 622
The clearance of dead cells by efferocytosis
Emilio Boada-Romero, Jennifer Martinez, Bradlee L. Heckmann, et al.
Nature Reviews Molecular Cell Biology (2020) Vol. 21, Iss. 7, pp. 398-414
Open Access | Times Cited: 585
The mechanism of HMGB1 secretion and release
Ruochan Chen, Rui Kang, Daolin Tang
Experimental & Molecular Medicine (2022) Vol. 54, Iss. 2, pp. 91-102
Open Access | Times Cited: 493
Release mechanisms of major DAMPs
Atsushi Murao, Monowar Aziz, Haichao Wang, et al.
APOPTOSIS (2021) Vol. 26, Iss. 3-4, pp. 152-162
Open Access | Times Cited: 383
S100A8/A9: From basic science to clinical application
Monika Pruenster, Thomas Vogl, Johannes Roth, et al.
Pharmacology & Therapeutics (2016) Vol. 167, pp. 120-131
Closed Access | Times Cited: 359
Inflammation-related pyroptosis, a novel programmed cell death pathway, and its crosstalk with immune therapy in cancer treatment
Sheng‐Kai Hsu, Chia‐Yang Li, I‐Ling Lin, et al.
Theranostics (2021) Vol. 11, Iss. 18, pp. 8813-8835
Open Access | Times Cited: 320
Extracellular HMGB1 as a therapeutic target in inflammatory diseases
Jan Andersson, Huan Yang, Helena Erlandsson Harris
Expert Opinion on Therapeutic Targets (2018) Vol. 22, Iss. 3, pp. 263-277
Closed Access | Times Cited: 253
Impact of HMGB1, RAGE, and TLR4 in Alzheimer’s Disease (AD): From Risk Factors to Therapeutic Targeting
Yam Nath Paudel, Efthalia Angelopoulou, Christina Piperi, et al.
Cells (2020) Vol. 9, Iss. 2, pp. 383-383
Open Access | Times Cited: 202
Switching from Apoptosis to Pyroptosis: Gasdermin-Elicited Inflammation and Antitumor Immunity
K. Tsuchiya
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 1, pp. 426-426
Open Access | Times Cited: 198
Urate‐induced immune programming: Consequences for gouty arthritis and hyperuricemia
Georgiana Cabău, Tania O. Crişan, Viola Klück, et al.
Immunological Reviews (2019) Vol. 294, Iss. 1, pp. 92-105
Open Access | Times Cited: 195
Platelet microparticles sustain autophagy-associated activation of neutrophils in systemic sclerosis
Norma Maugeri, Annalisa Capobianco, Patrizia Rovere‐Querini, et al.
Science Translational Medicine (2018) Vol. 10, Iss. 451
Open Access | Times Cited: 190
Danger-Associated Molecular Patterns (DAMPs): Molecular Triggers for Sterile Inflammation in the Liver
Sabine Mihm
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 10, pp. 3104-3104
Open Access | Times Cited: 180
Paraptosis: a unique cell death mode for targeting cancer
Sweata Hanson, Aiswarya Dharan, P. V. Jinsha, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 59
PAMPs and DAMPs in Sepsis: A Review of Their Molecular Features and Potential Clinical Implications
Sara Cicchinelli, Giulia Pignataro, Stefania Gemma, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 962-962
Open Access | Times Cited: 29
Multiple Targets of Salicylic Acid and Its Derivatives in Plants and Animals
Daniel F. Klessig, Miaoying Tian, Hyong Woo Choi
Frontiers in Immunology (2016) Vol. 7
Open Access | Times Cited: 150
Deep vein thrombosis in mice is regulated by platelet HMGB1 through release of neutrophil-extracellular traps and DNA
Mitchell Dyer, Qiwei Chen, Shannon Haldeman, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 141
Recent Advances in the Molecular Mechanisms Underlying Pyroptosis in Sepsis
Yulei Gao, Jianhua Zhai, Yanfen Chai
Mediators of Inflammation (2018) Vol. 2018, pp. 1-7
Open Access | Times Cited: 132
Oncolytic viruses: how “lytic” must they be for therapeutic efficacy?
María Eugenia Dávola, Karen L. Mossman
OncoImmunology (2019) Vol. 8, Iss. 6, pp. e1581528-e1581528
Open Access | Times Cited: 121
The interplay between Angiotensin II, TLR4 and hypertension
Vinicia C. Biancardi, Gisele Facholi Bomfim, Wagner Luis Reis, et al.
Pharmacological Research (2017) Vol. 120, pp. 88-96
Closed Access | Times Cited: 117
Identification of CD163 as an antiinflammatory receptor for HMGB1-haptoglobin complexes
Huan Yang, Haichao Wang, Yaakov A. Levine, et al.
JCI Insight (2016) Vol. 1, Iss. 7
Open Access | Times Cited: 116
Microglia: Neuroimmune-sensors of stress
Matthew G. Frank, Laura K. Fonken, Linda R. Watkins, et al.
Seminars in Cell and Developmental Biology (2019) Vol. 94, pp. 176-185
Open Access | Times Cited: 116
Crosstalk Between Liver Macrophages and Surrounding Cells in Nonalcoholic Steatohepatitis
Haiou Li, Yunjiao Zhou, Haizhou Wang, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 95
High Mobility Group Box-1 (HMGb1): Current Wisdom and Advancement as a Potential Drug Target
Sonya VanPatten, Yousef Al‐Abed
Journal of Medicinal Chemistry (2017) Vol. 61, Iss. 12, pp. 5093-5107
Open Access | Times Cited: 92
Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation
Huan Yang, Hui Liu, Qiong Zeng, et al.
Molecular Medicine (2019) Vol. 25, Iss. 1
Open Access | Times Cited: 88
Page 1 - Next Page

Scroll to top